Sosei
Navigation Links
Sosei in Medical News
Sosei Announces Start of AD 923 Phase III Studies in Europe
...OKYO, Japan, February 12 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...safety and tolerability of AD 923. In June 2006, sosei entered into an agreement with Mundipharma Interna...tional markets, excluding North America and Japan. sosei is currently evaluating its commercialisation opti...Sosei Announces Approval to Start AD 923 Phase III Studies in Europe
... TOKYO, November 28 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...in the trial". Notes to Editors: About Sosei sosei Group Corporation is a leading international bioph...ckout system that prevents inadvertent overdosing. sosei has concluded a range of studies that confirm the ...Sosei Announces Update on Phase I Trials for SD118
... TOKYO, November 27 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...ction that lead to improved drugs. About Sosei sosei Group Corporation is a leading international bioph...s on its lead compound NSL-043 in partnership with sosei Group Corporation, a listed Japanese biopharmaceut...Sosei and Vectura Announce Start of Phase II Studies of QVA149 for the Treatment of COPD
...AM, England, November 15 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...o severe COPD. NVA237 was licensed to Novartis by sosei and Vectura in 2005 in a deal in which the two com... About the NVA237 licence agreement with Novartis sosei and its co-development partner Vectura Group plc c...Sosei in Medical Technology
Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237
...riggers $7.5m Milestones for Both Companies sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...l trigger a $7.5 million milestone payment to both sosei and Vectura. The trial is a randomised, dou... NVA237 was licensed to Novartis in April 2005 by sosei and its co-development partner Vectura. Novartis i...Sosei Confirms the Safety of SD118 in Two Phase I Trials
... TOKYO, December 8 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...esia A reduced sense of touch. About sosei sosei Group is a leading international biopharmaceutical......service provider and drug development Company, and sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...nflammatory pain." Mr Shinichi Tamura, CEO sosei Group added: "We are pleased to have collaborated ...opment compound NSL-043/SD118, in partnership with sosei Co. Ltd. Both of these trials reported a successfu...
...lar findings. NVA237 was licensed to Novartis by sosei and Vectura in 2005 in a deal in which the two com...VA237 and QVA149 licence agreement with Novartis sosei and Vectura Group plc concluded a global developme...st, as QVA149. Under the terms of the agreement, sosei and Vectura to date have each received $15 million...
Sosei Announces Completion of Phase III Trial for NorLevo(R)
... TOKYO, July 10 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...ncy contraceptive pill (ECP) SOH-075 (NorLevo(R)). sosei acquired the exclusive distribution rights to the ...d as an essential drug by the WHO. About Sosei sosei Group is a leading international biopharmaceutical...Sosei Announces Successful Completion of AD 923 Pharmacokinetic Study in the USA
... TOKYO, May 22, 2007 /PRNewswire-FirstCall/ -- sosei Group Corporation , a biopharmaceutical company, t...with no significant safety issues identified. sosei has reached agreement with EU regulatory authoriti...o Phase III studies." Notes for Editors: About sosei ...Sosei in Biological Technology
New Report Just Published: World Prostate Cancer Therapeutics Market Report
...icenses Antibody-Drug Conjugates Development Rights to Genentech II-88 National Cancer Institute Enters into Agreement with Illumina II-89 sosei Seeks Marketing Rights for Prostate Cancer Drug in Japan II-89 8. Focus on Select Global Players II-90 Abbott Laboratories (USA) II-90 Ae...... Based on its cytokine modulatory activity, sosei were developing RS(+) mefloquine as AD 452 for the...es over existing treatment options." About sosei sosei Group is a leading international biopharmaceutical...
Sosei Agrees Terms With ASKA for Commercialisation of SOH-075 (NorLevo(R))
... TOKYO, October 22 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...he biopharmaceutical company, today announced that sosei Co., Ltd., its wholly owned Japanese subsidiary, h... oral emergency contraceptive for post-coital use. sosei acquired the exclusive distribution rights to the ...WWMR, Inc. Announces Launch of New Pain Clinic Monitor
...Reckitt Benckiser/Vernalis, Durect, Rinat Neuroscience/Pfizer, Elan Pharm, Roche, Eli Lilly, Sanofi-Aventis, Endo Pharm, Schwarz, Forest Laboratories, sosei R&D, Gedeon Richter, Teikoku Seiyaku, GlaxoSmithKline, TheraQuest, Grunenthal, Vernalis, GW Pharmaceuticals, Watson Pharm, Janssen-Cilag, Wyeth Pharma...Sosei Announces Outcome of Strategy Review
... TOKYO, May 14 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456...ness from NVA237/QVA149 in a few years time. - sosei is closing its Chesterford operation and sosei R&D's continuing business will relocate to London...Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities
... Prior to Marquant, Joy's positions included: Vice President, Business Development at Nabi Biopharmaceuticals; Vice President, Business Development at sosei Co. Ltd; Commercial Director at Xenova Group Limited; member of the Pharmaceuticals and Medical Products practice at Accenture; and various roles in t...Sosei Announces Completion of Phase II Trial of AD 337 in Fibromyalgia Syndrome
... TOKYO, September 18 /PRNewswire-FirstCall/ -- sosei Group Corporation ("Sosei"; TSE Mothers Index: 456... potential indications." Notes to Editors: About sosei sosei Group Corporation is a leading international bioph...Other TagsLivesLivesValveValveValveFloodSheerCornealOther Contentswobblecrystallographycrystallographycrystallographycrystallographyrayrayrayxylemxylemchromosomechromosomechromosomechromosomechromosomechromosomechromosomechromosomechromosomepellucidazonazona
(Date:11/29/2009)...l Dentistry (AGD) announces that Aria Irvani, DDS,...d during the AGD,s commencement celebration that r... dental education.,To accomplish this, Dr. Irvani...al education in the 16 disciplines of dentistry, i...d techniques. , (PRWEB) N...
(Date:11/29/2009)...ds to more self-defensive finger pointing, study f...) -- The blame game is a contagious one, a new stu... Researchers found that when people see someone bl...fair accusation, they,re much more likely to engag...s protecting their egos, we become defensive, too....
(Date:11/29/2009)...e,s uncertain future and rising costs open the doo...le Acupuncture Scottsdale answers the call. , ...Affordable Acupuncture, LLC opened in Scottsdale i...nthusiasm and gratitude. Its increasing popularity..., need and cost. "As far as I’m concer...
(Date:11/28/2009)...ircadian rhythm, , , FRIDAY, Nov. 2...n internal body clock that goes on the fritz could...r in children. , The finding results from the ...with bipolar disorder, which can make people susce...out the disorder. They linked variations in a gene...
(Date:11/27/2009)...s Ltd. today issued its latest biochemical analysi...he lethality of the virus has dropped from its pea...break in the spring of 2009 to resting non-epidemi...ectivity count, however, remains increased. , ...009 -- Biotech firm Replikins Ltd., which has anal...
Breaking Medicine News(10 mins):Health News:Orange County Dentist Honored by The Academy of General Dentistry 2Health News:When Accusations Start to Fly, They Multiply 2Health News:Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities 2Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5[1] Orange County Dentist Honored by The Academy of General Dentistry [1] When Accusations Start to Fly, They Multiply[0] Affordable Acupuncture Greeted with Open Arms by Scottsdale and Phoenix Communities[0] Bipolar Disorder May Be Tied to Body Clock[0] Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased
(Date:11/26/2009)...ht European countries has shown that closing schoo...could have a significant role in reducing illness ...ss journal BMC Infectious Diseases compared oppo...s/holidays, finding that they were reduced when sc...twerp University, Belgium, led a team of European ...
(Date:11/25/2009)... in the stomach, may be used to boost resistance t..., Yale School of Medicine researchers report in a ...of Neuroscience . , Parkinson,s disease is cause... of the midbrain known as the substantia nigra, wh...ed production of dopamine in late-stage Parkinson,...
(Date:11/25/2009)...me, the heart pumps some 250 million liters of blo...muscle fibers of the heart have to be extremely du...ottbauer, vice chair of the Department of Medicine...Prof. Dr. H. A. Katus), has discovered a protein t...st muscular unit, the sarcomere. In cooperation wi...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 6509 1CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 6509 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 6509 3IPC The Hospitalist Companys Philip Vaidyan M D Named a Top Hospitalist of 2009 6505 1IPC The Hospitalist Companys Philip Vaidyan M D Named a Top Hospitalist of 2009 6505 2Involving family in medical rounds benefits both family and medical team 62042 1Involving family in medical rounds benefits both family and medical team 62042 2Involving family in medical rounds benefits both family and medical team 62042 3Involving family in medical rounds benefits both family and medical team 62042 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |